A Case of Osimertinib-Induced Eosinophilic Pneumonia

Affiliations

¹ Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA.
² Division of Pulmonary and Critical Care, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA.
³ Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA.
⁴ Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA. Electronic address: jwriess@ucdavis.edu.

Free article

Case Reports

Kanishka G Patel et al. Clin Lung Cancer. 2022 Nov.

Free article

. 2022 Nov;23(7):639-642.

doi: 10.1016/j.cllc.2022.07.013. Epub 2022 Aug 7.

¹ Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA.
² Division of Pulmonary and Critical Care, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA.
³ Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA.
⁴ Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA. Electronic address: jwriess@ucdavis.edu.

No abstract available

Keywords: Interstitial lung disease; Lung adenocarcinoma; Malignant pleural effusion; Non-small cell lung cancer; Tyrosine kinase inhibitor.

Publication types